KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...
What shapes are made by a spinning needle? This seemingly innocent problem has puzzled mathematicians for decades, but now a ...
Irit Dinur's journey through mathematics and computer science led her to become the first woman professor at the Institute for Advanced Study.
Rouse had presented with symptoms including intense swelling in her legs that she originally thought could be linked to her ...
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...
Zacks Research lowered its Q3 2026 earnings estimate for Vertex Pharmaceuticals from $4.15 to $4.13 per share. Other analysts ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback